Increased intestinal permeability precedes clinical onset of type 1 diabetes
Recent observations have shown subclinical intestinal abnormalities in human type 1 diabetes. Whether these are related to the pathogenetic process or secondary to the diabetes remains to be clarified. The aim of this study was to investigate this issue by examining intestinal permeability to sugars in subjects at different stages of type 1 diabetes: preclinical, new-onset and long-term established disease.
Eighty-one subjects with islet autoimmunity (18 preclinical, 28 new-onset and 35 long-term type 1 diabetes) and 40 healthy control subjects were investigated by a lactulose-mannitol test, consisting of oral administration of the two sugars and measurement of their urinary excretion.
All groups of subjects with islet autoimmunity showed an increase in intestinal permeability (p ≤ 0.009 vs controls) to the disaccharide lactulose, indicative of a damaged barrier, but a similar permeability to the monosaccharide mannitol (NS vs controls), indicative of an integral surface mucosa; consequently there was an increase in the lactulose:mannitol excretion ratio (p ≤ 0.025 vs controls).
These findings indicate the presence of a subclinical enteropathy associated with type 1 diabetes that is already detectable before clinical onset of the disease, and suggest that the small intestine is an organ participating in the pathogenetic process of type 1 diabetes.
- Meddings JB, Jarand J, Urbanski SJ, Hardin J, Gall DG (1999) Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 276:G951–G957
- Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM (2004) Enteropathy precedes type 1 diabetes in the BB rat. Gut 53:1437–1444 CrossRef
- Neu J, Reverte CM, Mackey AD et al (2005) Changes in intestinal morphology and permeability in the BioBreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 40:589–595 CrossRef
- Maurano F, Mazzarella G, Luongo D et al (2005) Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. Diabetologia 48:931–937 CrossRef
- Mooradian AD, Morley JE, Levine AS, Prigge WF, Gebhard RL (1986) Abnormal intestinal permeability to sugars in diabetes mellitus. Diabetologia 29:221–224 CrossRef
- Carratu R, Secondulfo M, De Magistris L et al (1999) Altered intestinal permeability to mannitol in diabetes mellitus type I. J Pediatr Gastroenterol Nutr 28:264–269 CrossRef
- Sapone A, DeMagistris L, Pletzak M et al (2006) Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55:1443–1449 CrossRef
- Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E (2003) Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 52:2287–2295
- Secondulfo M, Iafusco D, Carratu R et al (2004) Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis 36:35–45 CrossRef
- Paroni R, Fermo I, Molteni L, Folini L, Pastore MR, Bosi E (2006) Lactulose and mannitol intestinal permeability detected by capillary electrophoresis. J Chromatogr B 834:183–187
- Increased intestinal permeability precedes clinical onset of type 1 diabetes
Volume 49, Issue 12 , pp 2824-2827
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Type 1 diabetes
- Islet antibodies
- Pre-clinical diabetes
- Intestinal permeability
- Industry Sectors
- Author Affiliations
- 1. General Medicine, Diabetes and Endocrinology Unit, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Via Olgettina 60, 20132, Milan, Italy
- 2. Separative Techniques Unit, San Raffaele Scientific Institute, Milan, Italy
- 3. Laboraf, Diagnostica e Ricerca San Raffaele, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy
- 4. Department of Medicine, Surgery and Dental Science, San Paolo Hospital, University of Milan, Milan, Italy